Related Experiment Video
Updated: May 23, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
MicroRNA-141 represses HBV replication by targeting PPARA
Wei Hu1, Xuejun Wang, Xiaoran Ding
1Beijing Institute of Radiation Medicine, Beijing, People's Republic of China.
Abstract:
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression primarily at the post-transcriptional level and play critical roles in a variety of physiological and pathological processes. In this report, miR-141 was identified to repress HBV expression by screening a small miRNA expressing library and synthetic miR-141 mimics could also significantly suppress HBV expression and replication in HepG2 cells. Bioinformatic analysis and experiment assays indicate that peroxisome proliferator-activated receptor alpha (PPARA) was the target of hsa-miR-141 during this process. Furthermore, knockdown of PPARA by small interfering RNA (siRNA) inhibited HBV replication similar to levels observed for miR-141. Promoter functional analysis indicated that repression of HBV replication by miR-141 mimics or siRNA was mediated by interfering with the HBV promoter functions, consistent with previous studies demonstrating that PPARA regulated HBV gene expression through interactions with HBV promoter regulatory elements. Our results suggest that miR-141 suppressed HBV replication by reducing HBV promoter activities by down-regulating PPARA. This study provides new insights into the molecular mechanisms associated with HBV-host interactions. Furthermore, this information may facilitate the development of novel anti-HBV therapeutic strategies.
Insights
MicroRNA-141 (miR-141) represses Hepatitis B virus (HBV) by targeting peroxisome proliferator-activated receptor alpha (PPARA). This down-regulation of PPARA reduces HBV replication and promoter activity, offering potential new anti-HBV therapies.
Area of Science:
- Molecular Biology
- Virology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression.
- Hepatitis B virus (HBV) infection is a significant global health concern.
- Understanding host-pathogen interactions is crucial for developing antiviral strategies.
Purpose of the Study:
- To identify specific microRNAs that regulate Hepatitis B virus (HBV) expression.
- To elucidate the molecular mechanism by which miR-141 affects HBV replication.
- To explore the potential of targeting the miR-141/PPARA axis for anti-HBV therapies.
Main Methods:
- Screening of a miRNA expression library to identify HBV-repressing miRNAs.
- Utilizing synthetic miR-141 mimics and small interfering RNA (siRNA) for knockdown experiments.
- Bioinformatic analysis and experimental validation to identify miRNA targets.
- Promoter functional assays to assess the impact on HBV gene expression.
Main Results:
- miR-141 was identified as a repressor of HBV expression and replication in HepG2 cells.
- Peroxisome proliferator-activated receptor alpha (PPARA) was validated as a direct target of hsa-miR-141.
- Knockdown of PPARA mimicked the anti-HBV effects of miR-141.
- miR-141 and PPARA modulated HBV replication by interfering with HBV promoter activity.
Conclusions:
- miR-141 suppresses HBV replication by down-regulating PPARA, leading to reduced HBV promoter activity.
- This study reveals a novel molecular mechanism in HBV-host interactions.
- The miR-141/PPARA pathway represents a potential therapeutic target for developing new anti-HBV strategies.
Related Concept Videos
Viruses with RNA Genomes
MicroRNAs
MicroRNAs
Hepatitis
Inhibitors of Viral Protein Synthesis
Experimental RNAi

